CME Group Inc. (NASDAQ: CME)
disclosed its financial performance for the fourth quarter and full year of
2023, showcasing strong figures across key metrics.
In the fourth quarter of 2023,
CME Group Inc. reported strong financial results, with revenue reaching $1.4
billion and operating income standing at $863 million.
Net income for the
quarter amounted to $815 million. Total revenue for the full year
2023 amounted to $5.6 billion, accompanied by operating income of $3.4 billion.
Net income for the year stood at $3.2 billion.
Terry Duffy, CME Group Chairman and CEO, Source: CME
“As global investors turned
to our deep, liquid markets to manage risk across asset classes, CME Group
average daily volume climbed to a record 24.4 million contracts in 2023,
generating both record revenue and adjusted earnings,” said Terry Duffy,
CME Group Chairman and Chief Executive Officer.
In the fourth quarter of 2023,
average daily volume (ADV) increased by 17% compared to the same period in 2022.
Non-US ADV saw a notable uptick of 28%. Revenue from clearing and
transaction fees in the fourth quarter of 2023 amounted to nearly $1.2 billion.
Market data revenue for the same period totaled $167 million.
Introducing CME FX Spot+:
Bridging Futures and Spot FX Markets
Earlier, CME
Group unveiled plans to launch CME FX Spot+ in 2024, a new spot foreign
exchange (FX) marketplace connecting spot FX traders with CME’s FX futures
liquidity pool, as reported by Finance
Magnates.
Using a central limit order book, the platform allows access to
CME’s futures liquidity in over-the-counter (OTC) spot terms and expands FX
futures traders’ access to OTC FX liquidity.
Leveraging FX Link, which connects OTC spot FX
and CME FX futures trading, CME FX Spot+ will be accessible through CME Globex
and EBS Market, benefiting EBS’ global spot FX customer base. Paul Houston, CME
Group’s Global Head of FX Products, emphasized the platform’s role in enhancing
access, transparency, and trading opportunities across spot FX and FX futures
markets.
CME Group Inc. (NASDAQ: CME)
disclosed its financial performance for the fourth quarter and full year of
2023, showcasing strong figures across key metrics.
In the fourth quarter of 2023,
CME Group Inc. reported strong financial results, with revenue reaching $1.4
billion and operating income standing at $863 million.
Net income for the
quarter amounted to $815 million. Total revenue for the full year
2023 amounted to $5.6 billion, accompanied by operating income of $3.4 billion.
Net income for the year stood at $3.2 billion.
Terry Duffy, CME Group Chairman and CEO, Source: CME
“As global investors turned
to our deep, liquid markets to manage risk across asset classes, CME Group
average daily volume climbed to a record 24.4 million contracts in 2023,
generating both record revenue and adjusted earnings,” said Terry Duffy,
CME Group Chairman and Chief Executive Officer.
In the fourth quarter of 2023,
average daily volume (ADV) increased by 17% compared to the same period in 2022.
Non-US ADV saw a notable uptick of 28%. Revenue from clearing and
transaction fees in the fourth quarter of 2023 amounted to nearly $1.2 billion.
Market data revenue for the same period totaled $167 million.
Introducing CME FX Spot+:
Bridging Futures and Spot FX Markets
Earlier, CME
Group unveiled plans to launch CME FX Spot+ in 2024, a new spot foreign
exchange (FX) marketplace connecting spot FX traders with CME’s FX futures
liquidity pool, as reported by Finance
Magnates.
Using a central limit order book, the platform allows access to
CME’s futures liquidity in over-the-counter (OTC) spot terms and expands FX
futures traders’ access to OTC FX liquidity.
Leveraging FX Link, which connects OTC spot FX
and CME FX futures trading, CME FX Spot+ will be accessible through CME Globex
and EBS Market, benefiting EBS’ global spot FX customer base. Paul Houston, CME
Group’s Global Head of FX Products, emphasized the platform’s role in enhancing
access, transparency, and trading opportunities across spot FX and FX futures
markets.
